These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 36915776)
1. RILPL2 is associated with the progression and prognosis of cervical squamous cell carcinoma and endocervical adenocarcinoma. Dong Y; Wen W; Yuan T; Liu L; Li X Am J Transl Res; 2023; 15(2):1072-1084. PubMed ID: 36915776 [TBL] [Abstract][Full Text] [Related]
2. ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification. Ding X; Wan A; Qi X; Jiang K; Liu Z; Chen B Curr Gene Ther; 2024; 24(5):441-452. PubMed ID: 38441026 [TBL] [Abstract][Full Text] [Related]
3. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis. Wu C; Ma C; Yuan J; Zhou P Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma. Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164 [No Abstract] [Full Text] [Related]
5. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification. Sun K; Huang C; Li JZ; Luo ZX World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777 [TBL] [Abstract][Full Text] [Related]
6. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900 [TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of the Anoikis-Related Gene Signature as a Novel Prognostic Model for Cervical Squamous Cell Carcinoma, Endocervical Adenocarcinoma, and Revelation Immune Infiltration. Jin QQ; Mei J; Hong L; Wang R; Wu SY; Wang SL; Jiang XY; Yang YT; Yao H; Zhang WY; Zhu YT; Ying J; Tian L; Chen G; Zhou SG Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837559 [No Abstract] [Full Text] [Related]
8. Ferroptosis-related genes identify tumor immune microenvironment characterization for the prediction of prognosis in cervical cancer. Yang X; Yin F; Liu Q; Ma Y; Zhang H; Guo P; Wen W; Guo X; Wu Y; Yang Z; Han Y Ann Transl Med; 2022 Jan; 10(2):123. PubMed ID: 35282071 [TBL] [Abstract][Full Text] [Related]
9. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer. Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026 [TBL] [Abstract][Full Text] [Related]
10. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer. Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503 [No Abstract] [Full Text] [Related]
11. Identification and validation of a novel necroptosis-related prognostic signature in cervical squamous cell carcinoma and endocervical adenocarcinoma. Zhang W; Cao W; Tong Z; Jin Q; Jiang X; Yang Y; Yao H; Chen G; Gao W; Zhu Y; Zhou S Front Oncol; 2022; 12():1011000. PubMed ID: 36185274 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database. He JY; Li ZM; Chen YT; Zhao BH; Yu C Transl Cancer Res; 2024 Apr; 13(4):1721-1736. PubMed ID: 38737688 [TBL] [Abstract][Full Text] [Related]
13. Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma. Liu J; Xu M; Wu Z; Yang Y; Yuan S; Liang J; Zhu H Front Mol Biosci; 2021; 8():670893. PubMed ID: 34095226 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213 [TBL] [Abstract][Full Text] [Related]
15. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma. Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of ferroptosis pathway gene signature and correlation with macrophage infiltration in cervical squamous cell carcinoma. Li CJ; Chang CH; Tsang YL; Fang SH; Chen SN; Chiang AJ Int Immunopharmacol; 2022 Nov; 112():109273. PubMed ID: 36183678 [TBL] [Abstract][Full Text] [Related]
17. Metabolism-associated molecular classification of cervical cancer. Zhao M; Zhang X; Huan Q; Dong M BMC Womens Health; 2023 Oct; 23(1):555. PubMed ID: 37884919 [TBL] [Abstract][Full Text] [Related]
18. Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis. Guo H; Wang S; Ju M; Yan P; Sun W; Li Z; Wu S; Lin R; Xian S; Yang D; Wang J; Huang Z Front Cell Dev Biol; 2021; 9():642724. PubMed ID: 33842467 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Alternative Splicing Genes in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. Wang X; Tang W; Lu Y; You J; Han Y; Zheng Y Int J Gen Med; 2021; 14():7933-7949. PubMed ID: 34785939 [TBL] [Abstract][Full Text] [Related]
20. Unraveling the role of the circadian clock genes in cervical squamous cell carcinoma and endocervical adenocarcinoma: A prognostic indicator for prognostic, immunotherapy response, and chemotherapy sensitivity. Xu J; Huang X; Gou S; Luo H; Zeng S; Zhang Q; Wu Q; Chi H; Yang G J Cancer; 2024; 15(9):2788-2804. PubMed ID: 38577592 [No Abstract] [Full Text] [Related] [Next] [New Search]